Ardelyx | ARDX - Equity Capital And Reserves


Ardelyx reported $154.28M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Abbott USD 50.83B 0 Sep/2025
Amgen USD 9.62B 2.19B Sep/2025
Ardelyx USD 154.28M 14.75M Sep/2025
aTyr Pharma USD 80.24M 5.58M Sep/2025
Corcept Therapeutics USD 631.9M 3.89M Sep/2025
Sanofi EUR 71.71B 14.25B Dec/2025
TG Therapeutics USD 607.22M 330.79M Sep/2025
United Therapeutics USD 6.59B 583.4M Sep/2025